SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
ERG
|
ENSG00000157554.14 | ETS transcription factor ERG |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
ERG | hg19_v2_chr21_-_39870339_39870443 | 0.95 | 1.0e-10 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_+_153330322 | 11.61 |
ENST00000368738.3
|
S100A9
|
S100 calcium binding protein A9 |
chr22_-_37640456 | 10.91 |
ENST00000405484.1
ENST00000441619.1 ENST00000406508.1 |
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
chr6_+_144665237 | 8.02 |
ENST00000421035.2
|
UTRN
|
utrophin |
chr12_-_52887034 | 7.84 |
ENST00000330722.6
|
KRT6A
|
keratin 6A |
chr1_-_59043166 | 7.40 |
ENST00000371225.2
|
TACSTD2
|
tumor-associated calcium signal transducer 2 |
chr15_+_43885252 | 6.89 |
ENST00000453782.1
ENST00000300283.6 ENST00000437924.1 ENST00000450086.2 |
CKMT1B
|
creatine kinase, mitochondrial 1B |
chr15_+_41136216 | 6.81 |
ENST00000562057.1
ENST00000344051.4 |
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
chr5_-_138862326 | 6.36 |
ENST00000330794.4
|
TMEM173
|
transmembrane protein 173 |
chr1_-_209957882 | 6.31 |
ENST00000294811.1
|
C1orf74
|
chromosome 1 open reading frame 74 |
chr22_-_37640277 | 6.05 |
ENST00000401529.3
ENST00000249071.6 |
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
chr4_+_2814011 | 6.00 |
ENST00000502260.1
ENST00000435136.2 |
SH3BP2
|
SH3-domain binding protein 2 |
chr1_+_40506255 | 5.98 |
ENST00000421589.1
|
CAP1
|
CAP, adenylate cyclase-associated protein 1 (yeast) |
chr11_-_118122996 | 5.77 |
ENST00000525386.1
ENST00000527472.1 ENST00000278949.4 |
MPZL3
|
myelin protein zero-like 3 |
chr5_-_151066514 | 5.77 |
ENST00000538026.1
ENST00000522348.1 ENST00000521569.1 |
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin) |
chr4_+_100737954 | 5.74 |
ENST00000296414.7
ENST00000512369.1 |
DAPP1
|
dual adaptor of phosphotyrosine and 3-phosphoinositides |
chr8_+_22437664 | 5.72 |
ENST00000436754.1
ENST00000426493.1 ENST00000429812.1 |
PDLIM2
|
PDZ and LIM domain 2 (mystique) |
chr8_+_124194752 | 5.69 |
ENST00000318462.6
|
FAM83A
|
family with sequence similarity 83, member A |
chr3_-_121379739 | 5.56 |
ENST00000428394.2
ENST00000314583.3 |
HCLS1
|
hematopoietic cell-specific Lyn substrate 1 |
chr15_+_43985084 | 5.53 |
ENST00000434505.1
ENST00000411750.1 |
CKMT1A
|
creatine kinase, mitochondrial 1A |
chr8_+_124194875 | 5.51 |
ENST00000522648.1
ENST00000276699.6 |
FAM83A
|
family with sequence similarity 83, member A |
chr15_+_41136734 | 5.44 |
ENST00000568580.1
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
chr15_+_41136586 | 5.43 |
ENST00000431806.1
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
chr17_-_7165662 | 5.28 |
ENST00000571881.2
ENST00000360325.7 |
CLDN7
|
claudin 7 |
chr15_+_43985725 | 5.26 |
ENST00000413453.2
|
CKMT1A
|
creatine kinase, mitochondrial 1A |
chr14_+_24867992 | 5.20 |
ENST00000382554.3
|
NYNRIN
|
NYN domain and retroviral integrase containing |
chr11_+_34645791 | 5.13 |
ENST00000529527.1
ENST00000531728.1 ENST00000525253.1 |
EHF
|
ets homologous factor |
chr7_-_3083573 | 5.03 |
ENST00000396946.4
|
CARD11
|
caspase recruitment domain family, member 11 |
chr4_+_2813946 | 5.00 |
ENST00000442312.2
|
SH3BP2
|
SH3-domain binding protein 2 |
chr5_-_138861926 | 4.93 |
ENST00000510817.1
|
TMEM173
|
transmembrane protein 173 |
chr1_-_153538292 | 4.92 |
ENST00000497140.1
ENST00000368708.3 |
S100A2
|
S100 calcium binding protein A2 |
chr1_+_209859510 | 4.88 |
ENST00000367028.2
ENST00000261465.1 |
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1 |
chr2_+_113885138 | 4.87 |
ENST00000409930.3
|
IL1RN
|
interleukin 1 receptor antagonist |
chr1_+_40506392 | 4.81 |
ENST00000414893.1
ENST00000414281.1 ENST00000420216.1 ENST00000372792.2 ENST00000372798.1 ENST00000340450.3 ENST00000372805.3 ENST00000435719.1 ENST00000427843.1 ENST00000417287.1 ENST00000424977.1 ENST00000446031.1 |
CAP1
|
CAP, adenylate cyclase-associated protein 1 (yeast) |
chr17_+_1674982 | 4.80 |
ENST00000572048.1
ENST00000573763.1 |
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
chr7_-_143105941 | 4.73 |
ENST00000275815.3
|
EPHA1
|
EPH receptor A1 |
chr5_+_137801160 | 4.68 |
ENST00000239938.4
|
EGR1
|
early growth response 1 |
chr19_+_16177826 | 4.68 |
ENST00000589897.1
|
TPM4
|
tropomyosin 4 |
chr1_-_209792111 | 4.67 |
ENST00000455193.1
|
LAMB3
|
laminin, beta 3 |
chr2_+_85804614 | 4.65 |
ENST00000263864.5
ENST00000409760.1 |
VAMP8
|
vesicle-associated membrane protein 8 |
chr18_+_61143994 | 4.56 |
ENST00000382771.4
|
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5 |
chr15_+_41136369 | 4.56 |
ENST00000563656.1
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
chr3_+_122044084 | 4.56 |
ENST00000264474.3
ENST00000479204.1 |
CSTA
|
cystatin A (stefin A) |
chr3_-_151034734 | 4.53 |
ENST00000260843.4
|
GPR87
|
G protein-coupled receptor 87 |
chr1_+_158985457 | 4.53 |
ENST00000567661.1
ENST00000474473.1 |
IFI16
|
interferon, gamma-inducible protein 16 |
chr7_+_40174565 | 4.52 |
ENST00000309930.5
ENST00000401647.2 ENST00000335693.4 ENST00000413931.1 ENST00000416370.1 ENST00000540834.1 |
C7orf10
|
succinylCoA:glutarate-CoA transferase |
chr12_-_52912901 | 4.52 |
ENST00000551188.1
|
KRT5
|
keratin 5 |
chr1_+_40505891 | 4.46 |
ENST00000372797.3
ENST00000372802.1 ENST00000449311.1 |
CAP1
|
CAP, adenylate cyclase-associated protein 1 (yeast) |
chr1_-_201368653 | 4.44 |
ENST00000367313.3
|
LAD1
|
ladinin 1 |
chr1_+_10003486 | 4.41 |
ENST00000403197.1
ENST00000377205.1 |
NMNAT1
|
nicotinamide nucleotide adenylyltransferase 1 |
chr7_-_143991230 | 4.31 |
ENST00000543357.1
|
ARHGEF35
|
Rho guanine nucleotide exchange factor (GEF) 35 |
chr1_-_201368707 | 4.23 |
ENST00000391967.2
|
LAD1
|
ladinin 1 |
chr17_-_7167279 | 4.20 |
ENST00000571932.2
|
CLDN7
|
claudin 7 |
chr1_+_153003671 | 4.18 |
ENST00000307098.4
|
SPRR1B
|
small proline-rich protein 1B |
chr17_-_39093672 | 4.17 |
ENST00000209718.3
ENST00000436344.3 ENST00000485751.1 |
KRT23
|
keratin 23 (histone deacetylase inducible) |
chr19_-_53141584 | 4.14 |
ENST00000597161.1
ENST00000596930.1 ENST00000545872.1 ENST00000544146.1 ENST00000536937.1 ENST00000301096.3 |
ZNF83
|
zinc finger protein 83 |
chr15_+_101420028 | 4.07 |
ENST00000557963.1
ENST00000346623.6 |
ALDH1A3
|
aldehyde dehydrogenase 1 family, member A3 |
chr1_+_154193643 | 4.05 |
ENST00000456325.1
|
UBAP2L
|
ubiquitin associated protein 2-like |
chr20_-_1306391 | 4.05 |
ENST00000339987.3
|
SDCBP2
|
syndecan binding protein (syntenin) 2 |
chr17_-_39681578 | 4.02 |
ENST00000593096.1
|
KRT19
|
keratin 19 |
chr4_-_153601136 | 4.00 |
ENST00000504064.1
ENST00000304385.3 |
TMEM154
|
transmembrane protein 154 |
chr11_+_129245796 | 3.96 |
ENST00000281437.4
|
BARX2
|
BARX homeobox 2 |
chr7_-_143892748 | 3.94 |
ENST00000378115.2
|
ARHGEF35
|
Rho guanine nucleotide exchange factor (GEF) 35 |
chr16_-_2908155 | 3.93 |
ENST00000571228.1
ENST00000161006.3 |
PRSS22
|
protease, serine, 22 |
chr11_-_118889323 | 3.91 |
ENST00000527673.1
|
RPS25
|
ribosomal protein S25 |
chr17_-_7166500 | 3.87 |
ENST00000575313.1
ENST00000397317.4 |
CLDN7
|
claudin 7 |
chr21_-_33984456 | 3.75 |
ENST00000431216.1
ENST00000553001.1 ENST00000440966.1 |
AP000275.65
C21orf59
|
Uncharacterized protein chromosome 21 open reading frame 59 |
chr7_+_144052381 | 3.72 |
ENST00000498580.1
ENST00000056217.5 |
ARHGEF5
|
Rho guanine nucleotide exchange factor (GEF) 5 |
chr1_+_36789335 | 3.71 |
ENST00000373137.2
|
RP11-268J15.5
|
RP11-268J15.5 |
chr1_+_156030937 | 3.67 |
ENST00000361084.5
|
RAB25
|
RAB25, member RAS oncogene family |
chrX_-_48326764 | 3.67 |
ENST00000413668.1
ENST00000441948.1 |
SLC38A5
|
solute carrier family 38, member 5 |
chr1_-_27286897 | 3.66 |
ENST00000320567.5
|
C1orf172
|
chromosome 1 open reading frame 172 |
chr7_+_150020363 | 3.64 |
ENST00000359623.4
ENST00000493307.1 |
LRRC61
|
leucine rich repeat containing 61 |
chr19_-_53324884 | 3.60 |
ENST00000457749.2
ENST00000414252.2 ENST00000391783.2 |
ZNF28
|
zinc finger protein 28 |
chr17_+_48610074 | 3.58 |
ENST00000503690.1
ENST00000514874.1 ENST00000537145.1 ENST00000541226.1 |
EPN3
|
epsin 3 |
chr19_+_42254885 | 3.56 |
ENST00000595740.1
|
CEACAM6
|
carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) |
chr7_+_157129738 | 3.56 |
ENST00000437030.1
|
DNAJB6
|
DnaJ (Hsp40) homolog, subfamily B, member 6 |
chr1_+_16083154 | 3.52 |
ENST00000375771.1
|
FBLIM1
|
filamin binding LIM protein 1 |
chr1_-_17304771 | 3.52 |
ENST00000375534.3
|
MFAP2
|
microfibrillar-associated protein 2 |
chr5_-_39274617 | 3.51 |
ENST00000510188.1
|
FYB
|
FYN binding protein |
chr9_-_21974820 | 3.50 |
ENST00000579122.1
ENST00000498124.1 |
CDKN2A
|
cyclin-dependent kinase inhibitor 2A |
chr12_+_7072354 | 3.50 |
ENST00000537269.1
|
U47924.27
|
U47924.27 |
chr2_+_233925064 | 3.49 |
ENST00000359570.5
ENST00000538935.1 |
INPP5D
|
inositol polyphosphate-5-phosphatase, 145kDa |
chr12_-_50616122 | 3.49 |
ENST00000552823.1
ENST00000552909.1 |
LIMA1
|
LIM domain and actin binding 1 |
chr1_-_153044083 | 3.48 |
ENST00000341611.2
|
SPRR2B
|
small proline-rich protein 2B |
chr3_-_58652523 | 3.46 |
ENST00000489857.1
ENST00000358781.2 |
FAM3D
|
family with sequence similarity 3, member D |
chr15_-_83952071 | 3.45 |
ENST00000569704.1
|
BNC1
|
basonuclin 1 |
chr4_+_2800722 | 3.44 |
ENST00000508385.1
|
SH3BP2
|
SH3-domain binding protein 2 |
chr1_-_153029980 | 3.43 |
ENST00000392653.2
|
SPRR2A
|
small proline-rich protein 2A |
chr5_+_125758865 | 3.41 |
ENST00000542322.1
ENST00000544396.1 |
GRAMD3
|
GRAM domain containing 3 |
chr1_+_203595903 | 3.40 |
ENST00000367218.3
ENST00000367219.3 ENST00000391954.2 |
ATP2B4
|
ATPase, Ca++ transporting, plasma membrane 4 |
chr1_+_86889769 | 3.40 |
ENST00000370565.4
|
CLCA2
|
chloride channel accessory 2 |
chr1_-_6546001 | 3.37 |
ENST00000400913.1
|
PLEKHG5
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 5 |
chr1_+_152974218 | 3.34 |
ENST00000331860.3
ENST00000443178.1 ENST00000295367.4 |
SPRR3
|
small proline-rich protein 3 |
chr3_-_185542761 | 3.31 |
ENST00000457616.2
ENST00000346192.3 |
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2 |
chr15_+_43885799 | 3.31 |
ENST00000449946.1
ENST00000417289.1 |
CKMT1B
|
creatine kinase, mitochondrial 1B |
chr6_-_31620095 | 3.29 |
ENST00000424176.1
ENST00000456622.1 |
BAG6
|
BCL2-associated athanogene 6 |
chr21_-_33985127 | 3.28 |
ENST00000290155.3
|
C21orf59
|
chromosome 21 open reading frame 59 |
chr14_-_24729251 | 3.27 |
ENST00000559136.1
|
TGM1
|
transglutaminase 1 |
chr2_-_230786032 | 3.27 |
ENST00000428959.1
|
TRIP12
|
thyroid hormone receptor interactor 12 |
chr12_-_50616382 | 3.26 |
ENST00000552783.1
|
LIMA1
|
LIM domain and actin binding 1 |
chr3_+_50284321 | 3.24 |
ENST00000451956.1
|
GNAI2
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 |
chr1_-_6545502 | 3.22 |
ENST00000535355.1
|
PLEKHG5
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 5 |
chr1_-_28520447 | 3.20 |
ENST00000539896.1
|
PTAFR
|
platelet-activating factor receptor |
chr5_+_125758813 | 3.18 |
ENST00000285689.3
ENST00000515200.1 |
GRAMD3
|
GRAM domain containing 3 |
chr8_-_134309823 | 3.17 |
ENST00000414097.2
|
NDRG1
|
N-myc downstream regulated 1 |
chr3_-_185542817 | 3.14 |
ENST00000382199.2
|
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2 |
chr12_-_15114603 | 3.14 |
ENST00000228945.4
|
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta |
chr12_+_48876275 | 3.13 |
ENST00000314014.2
|
C12orf54
|
chromosome 12 open reading frame 54 |
chr19_-_4338783 | 3.11 |
ENST00000601482.1
ENST00000600324.1 |
STAP2
|
signal transducing adaptor family member 2 |
chr11_+_34642656 | 3.08 |
ENST00000257831.3
ENST00000450654.2 |
EHF
|
ets homologous factor |
chr19_-_42947121 | 3.07 |
ENST00000601181.1
|
CXCL17
|
chemokine (C-X-C motif) ligand 17 |
chr19_+_52901094 | 3.07 |
ENST00000391788.2
ENST00000436397.1 ENST00000391787.2 ENST00000360465.3 ENST00000494167.2 ENST00000493272.1 |
ZNF528
|
zinc finger protein 528 |
chr1_-_39407467 | 3.07 |
ENST00000540558.1
|
RHBDL2
|
rhomboid, veinlet-like 2 (Drosophila) |
chr8_-_134309335 | 3.05 |
ENST00000522890.1
ENST00000323851.7 ENST00000518176.1 ENST00000354944.5 ENST00000537882.1 ENST00000522476.1 ENST00000518066.1 ENST00000521544.1 ENST00000518480.1 ENST00000523892.1 |
NDRG1
|
N-myc downstream regulated 1 |
chr6_-_31620403 | 3.05 |
ENST00000451898.1
ENST00000439687.2 ENST00000362049.6 ENST00000424480.1 |
BAG6
|
BCL2-associated athanogene 6 |
chr1_-_111746966 | 3.04 |
ENST00000369752.5
|
DENND2D
|
DENN/MADD domain containing 2D |
chr9_+_132094579 | 3.04 |
ENST00000427109.1
|
RP11-65J3.1
|
RP11-65J3.1 |
chr19_-_53289995 | 3.03 |
ENST00000338230.3
|
ZNF600
|
zinc finger protein 600 |
chr6_-_28304152 | 3.03 |
ENST00000435857.1
|
ZSCAN31
|
zinc finger and SCAN domain containing 31 |
chr5_+_96211643 | 3.02 |
ENST00000437043.3
ENST00000510373.1 |
ERAP2
|
endoplasmic reticulum aminopeptidase 2 |
chr11_+_131781290 | 3.02 |
ENST00000425719.2
ENST00000374784.1 |
NTM
|
neurotrimin |
chr8_-_49834299 | 3.01 |
ENST00000396822.1
|
SNAI2
|
snail family zinc finger 2 |
chr1_+_116519112 | 3.01 |
ENST00000369503.4
|
SLC22A15
|
solute carrier family 22, member 15 |
chr12_-_6484376 | 3.00 |
ENST00000360168.3
ENST00000358945.3 |
SCNN1A
|
sodium channel, non-voltage-gated 1 alpha subunit |
chr6_-_33267101 | 2.99 |
ENST00000497454.1
|
RGL2
|
ral guanine nucleotide dissociation stimulator-like 2 |
chr6_-_47010061 | 2.98 |
ENST00000371253.2
|
GPR110
|
G protein-coupled receptor 110 |
chr6_-_28303901 | 2.98 |
ENST00000439158.1
ENST00000446474.1 ENST00000414431.1 ENST00000344279.6 ENST00000453745.1 |
ZSCAN31
|
zinc finger and SCAN domain containing 31 |
chr1_-_183559693 | 2.98 |
ENST00000367535.3
ENST00000413720.1 ENST00000418089.1 |
NCF2
|
neutrophil cytosolic factor 2 |
chr19_-_6481776 | 2.97 |
ENST00000543576.1
ENST00000590173.1 ENST00000381480.2 |
DENND1C
|
DENN/MADD domain containing 1C |
chr4_-_10023095 | 2.94 |
ENST00000264784.3
|
SLC2A9
|
solute carrier family 2 (facilitated glucose transporter), member 9 |
chr1_+_158979686 | 2.94 |
ENST00000368132.3
ENST00000295809.7 |
IFI16
|
interferon, gamma-inducible protein 16 |
chr1_-_25558984 | 2.93 |
ENST00000236273.4
|
SYF2
|
SYF2 pre-mRNA-splicing factor |
chr12_-_6483969 | 2.93 |
ENST00000396966.2
|
SCNN1A
|
sodium channel, non-voltage-gated 1 alpha subunit |
chr19_-_11688500 | 2.92 |
ENST00000433365.2
|
ACP5
|
acid phosphatase 5, tartrate resistant |
chrX_+_135614293 | 2.91 |
ENST00000370634.3
|
VGLL1
|
vestigial like 1 (Drosophila) |
chr19_+_11877838 | 2.90 |
ENST00000357901.4
ENST00000454339.2 |
ZNF441
|
zinc finger protein 441 |
chr1_+_158979680 | 2.89 |
ENST00000368131.4
ENST00000340979.6 |
IFI16
|
interferon, gamma-inducible protein 16 |
chr9_-_117880477 | 2.88 |
ENST00000534839.1
ENST00000340094.3 ENST00000535648.1 ENST00000346706.3 ENST00000345230.3 ENST00000350763.4 |
TNC
|
tenascin C |
chr19_-_52674896 | 2.88 |
ENST00000322146.8
ENST00000597065.1 |
ZNF836
|
zinc finger protein 836 |
chr7_+_150020329 | 2.86 |
ENST00000323078.7
|
LRRC61
|
leucine rich repeat containing 61 |
chr6_-_42110342 | 2.85 |
ENST00000356542.5
|
C6orf132
|
chromosome 6 open reading frame 132 |
chr12_-_123380610 | 2.85 |
ENST00000535765.1
|
VPS37B
|
vacuolar protein sorting 37 homolog B (S. cerevisiae) |
chr19_+_53073526 | 2.83 |
ENST00000596514.1
ENST00000391785.3 ENST00000301093.2 |
ZNF701
|
zinc finger protein 701 |
chr2_+_27665232 | 2.83 |
ENST00000543753.1
ENST00000288873.3 |
KRTCAP3
|
keratinocyte associated protein 3 |
chr20_+_37230511 | 2.82 |
ENST00000373345.4
|
ARHGAP40
|
Rho GTPase activating protein 40 |
chr7_+_99613212 | 2.82 |
ENST00000426572.1
ENST00000535170.1 |
ZKSCAN1
|
zinc finger with KRAB and SCAN domains 1 |
chr2_+_158114051 | 2.82 |
ENST00000259056.4
|
GALNT5
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 5 (GalNAc-T5) |
chr15_-_75017711 | 2.82 |
ENST00000567032.1
ENST00000564596.1 ENST00000566503.1 ENST00000395049.4 ENST00000395048.2 ENST00000379727.3 |
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1 |
chr1_-_39407450 | 2.81 |
ENST00000372990.1
|
RHBDL2
|
rhomboid, veinlet-like 2 (Drosophila) |
chr15_-_23932437 | 2.81 |
ENST00000331837.4
|
NDN
|
necdin, melanoma antigen (MAGE) family member |
chr2_-_230786378 | 2.80 |
ENST00000430954.1
|
TRIP12
|
thyroid hormone receptor interactor 12 |
chr8_-_10588010 | 2.78 |
ENST00000304501.1
|
SOX7
|
SRY (sex determining region Y)-box 7 |
chr9_-_130616915 | 2.77 |
ENST00000344849.3
|
ENG
|
endoglin |
chr1_+_24742264 | 2.76 |
ENST00000374399.4
ENST00000003912.3 ENST00000358028.4 ENST00000339255.2 |
NIPAL3
|
NIPA-like domain containing 3 |
chr8_-_42397037 | 2.76 |
ENST00000342228.3
|
SLC20A2
|
solute carrier family 20 (phosphate transporter), member 2 |
chr21_-_33984888 | 2.75 |
ENST00000382549.4
ENST00000540881.1 |
C21orf59
|
chromosome 21 open reading frame 59 |
chr18_+_61420169 | 2.75 |
ENST00000425392.1
ENST00000336429.2 |
SERPINB7
|
serpin peptidase inhibitor, clade B (ovalbumin), member 7 |
chr1_+_24969755 | 2.73 |
ENST00000447431.2
ENST00000374389.4 |
SRRM1
|
serine/arginine repetitive matrix 1 |
chr4_-_90758227 | 2.72 |
ENST00000506691.1
ENST00000394986.1 ENST00000506244.1 ENST00000394989.2 ENST00000394991.3 |
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor) |
chr17_-_5522731 | 2.68 |
ENST00000576905.1
|
NLRP1
|
NLR family, pyrin domain containing 1 |
chr12_-_15114191 | 2.67 |
ENST00000541380.1
|
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta |
chr8_+_82192501 | 2.67 |
ENST00000297258.6
|
FABP5
|
fatty acid binding protein 5 (psoriasis-associated) |
chr1_+_107599267 | 2.66 |
ENST00000361318.5
ENST00000370078.1 |
PRMT6
|
protein arginine methyltransferase 6 |
chr6_-_31619892 | 2.66 |
ENST00000454165.1
ENST00000428326.1 ENST00000452994.1 |
BAG6
|
BCL2-associated athanogene 6 |
chr12_-_123187890 | 2.66 |
ENST00000328880.5
|
HCAR2
|
hydroxycarboxylic acid receptor 2 |
chr1_-_95285764 | 2.64 |
ENST00000414374.1
ENST00000421997.1 ENST00000418366.2 ENST00000452922.1 |
LINC01057
|
long intergenic non-protein coding RNA 1057 |
chr1_+_13910194 | 2.64 |
ENST00000376057.4
ENST00000510906.1 |
PDPN
|
podoplanin |
chr6_-_47009996 | 2.64 |
ENST00000371243.2
|
GPR110
|
G protein-coupled receptor 110 |
chr19_-_46916805 | 2.63 |
ENST00000307522.3
|
CCDC8
|
coiled-coil domain containing 8 |
chr22_+_40390930 | 2.63 |
ENST00000333407.6
|
FAM83F
|
family with sequence similarity 83, member F |
chr19_-_9811347 | 2.61 |
ENST00000585964.1
ENST00000457674.2 ENST00000590544.1 |
ZNF812
|
zinc finger protein 812 |
chr1_-_28520384 | 2.60 |
ENST00000305392.3
|
PTAFR
|
platelet-activating factor receptor |
chr6_+_41604747 | 2.59 |
ENST00000419164.1
ENST00000373051.2 |
MDFI
|
MyoD family inhibitor |
chr19_+_53868940 | 2.59 |
ENST00000474037.1
ENST00000491101.1 ENST00000467003.1 ENST00000475179.1 ENST00000593918.1 |
ZNF525
|
zinc finger protein 525 |
chr6_+_163837347 | 2.59 |
ENST00000544436.1
|
QKI
|
QKI, KH domain containing, RNA binding |
chr16_+_2880157 | 2.58 |
ENST00000382280.3
|
ZG16B
|
zymogen granule protein 16B |
chr10_+_72972281 | 2.58 |
ENST00000335350.6
|
UNC5B
|
unc-5 homolog B (C. elegans) |
chr17_+_48610042 | 2.57 |
ENST00000503246.1
|
EPN3
|
epsin 3 |
chr20_-_45142154 | 2.56 |
ENST00000347606.4
ENST00000457685.2 |
ZNF334
|
zinc finger protein 334 |
chr1_+_12538594 | 2.55 |
ENST00000543710.1
|
VPS13D
|
vacuolar protein sorting 13 homolog D (S. cerevisiae) |
chr6_-_32160622 | 2.54 |
ENST00000487761.1
ENST00000375040.3 |
GPSM3
|
G-protein signaling modulator 3 |
chr12_-_15114492 | 2.54 |
ENST00000541546.1
|
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta |
chr10_+_71075516 | 2.54 |
ENST00000436817.1
|
HK1
|
hexokinase 1 |
chr5_+_96212185 | 2.53 |
ENST00000379904.4
|
ERAP2
|
endoplasmic reticulum aminopeptidase 2 |
chr13_-_43566301 | 2.53 |
ENST00000398762.3
ENST00000313640.7 ENST00000313624.7 |
EPSTI1
|
epithelial stromal interaction 1 (breast) |
chr15_+_74833518 | 2.51 |
ENST00000346246.5
|
ARID3B
|
AT rich interactive domain 3B (BRIGHT-like) |
chr15_+_39873268 | 2.50 |
ENST00000397591.2
ENST00000260356.5 |
THBS1
|
thrombospondin 1 |
chr19_-_5851442 | 2.49 |
ENST00000458379.2
ENST00000589714.1 ENST00000589918.1 ENST00000303225.6 ENST00000589620.1 |
FUT3
|
fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group) |
chr6_-_32784687 | 2.49 |
ENST00000447394.1
ENST00000438763.2 |
HLA-DOB
|
major histocompatibility complex, class II, DO beta |
chr19_-_41934635 | 2.48 |
ENST00000321702.2
|
B3GNT8
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8 |
chr14_-_24711764 | 2.48 |
ENST00000557921.1
ENST00000558476.1 |
TINF2
|
TERF1 (TRF1)-interacting nuclear factor 2 |
chr12_-_120687948 | 2.47 |
ENST00000458477.2
|
PXN
|
paxillin |
chr13_-_46626847 | 2.47 |
ENST00000242848.4
ENST00000282007.3 |
ZC3H13
|
zinc finger CCCH-type containing 13 |
chr10_+_112631699 | 2.47 |
ENST00000444997.1
|
PDCD4
|
programmed cell death 4 (neoplastic transformation inhibitor) |
chr17_+_7942424 | 2.47 |
ENST00000573359.1
|
ALOX15B
|
arachidonate 15-lipoxygenase, type B |
chr11_-_64612041 | 2.45 |
ENST00000342711.5
|
CDC42BPG
|
CDC42 binding protein kinase gamma (DMPK-like) |
chr11_+_5710919 | 2.43 |
ENST00000379965.3
ENST00000425490.1 |
TRIM22
|
tripartite motif containing 22 |
chr1_+_158978768 | 2.43 |
ENST00000447473.2
|
IFI16
|
interferon, gamma-inducible protein 16 |
chr17_+_7255208 | 2.42 |
ENST00000333751.3
|
KCTD11
|
potassium channel tetramerization domain containing 11 |
chr18_+_72166564 | 2.42 |
ENST00000583216.1
ENST00000581912.1 ENST00000582589.1 |
CNDP2
|
CNDP dipeptidase 2 (metallopeptidase M20 family) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.9 | 11.7 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
2.3 | 6.8 | GO:1990764 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
2.1 | 6.4 | GO:0033242 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
2.0 | 6.0 | GO:0001300 | chronological cell aging(GO:0001300) |
2.0 | 7.8 | GO:0001897 | cytolysis by symbiont of host cells(GO:0001897) |
1.9 | 5.8 | GO:0071258 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
1.9 | 1.9 | GO:0060491 | regulation of cell projection assembly(GO:0060491) |
1.7 | 5.1 | GO:0045360 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
1.7 | 18.7 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
1.7 | 16.7 | GO:1904327 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
1.7 | 5.0 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
1.6 | 4.7 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
1.5 | 10.4 | GO:0071461 | cellular response to redox state(GO:0071461) |
1.4 | 4.2 | GO:1904761 | negative regulation of myofibroblast differentiation(GO:1904761) |
1.2 | 7.0 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
1.1 | 5.5 | GO:1903285 | negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) positive regulation of peroxidase activity(GO:2000470) |
1.1 | 3.3 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
1.0 | 4.1 | GO:0060166 | olfactory pit development(GO:0060166) |
1.0 | 26.3 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
1.0 | 3.0 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
0.9 | 2.8 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
0.9 | 0.9 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
0.9 | 5.5 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.9 | 9.2 | GO:0033183 | negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
0.9 | 2.7 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
0.9 | 2.7 | GO:0034970 | histone H3-R2 methylation(GO:0034970) |
0.8 | 9.9 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
0.8 | 0.8 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
0.8 | 6.4 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
0.8 | 6.4 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.8 | 4.0 | GO:1904579 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
0.8 | 2.4 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.8 | 2.4 | GO:0021503 | neural fold bending(GO:0021503) |
0.8 | 4.7 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.8 | 0.8 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.8 | 2.3 | GO:0060545 | positive regulation of necroptotic process(GO:0060545) |
0.7 | 5.2 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.7 | 5.2 | GO:0014718 | positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) |
0.7 | 2.2 | GO:0060086 | circadian temperature homeostasis(GO:0060086) |
0.7 | 2.2 | GO:1900180 | regulation of protein localization to nucleus(GO:1900180) |
0.7 | 7.4 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.7 | 3.6 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
0.7 | 2.9 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.7 | 4.3 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.7 | 2.1 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.7 | 13.2 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.7 | 3.5 | GO:0097403 | cellular response to raffinose(GO:0097403) response to raffinose(GO:1901545) |
0.7 | 4.1 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.7 | 2.8 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
0.7 | 2.0 | GO:2000338 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) positive regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000340) |
0.7 | 5.9 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.6 | 6.4 | GO:0060717 | chorion development(GO:0060717) |
0.6 | 4.5 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.6 | 2.5 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.6 | 1.9 | GO:0051102 | DNA ligation involved in DNA recombination(GO:0051102) |
0.6 | 4.9 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.6 | 2.4 | GO:2000434 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
0.6 | 3.0 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.6 | 5.4 | GO:1903758 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.6 | 2.4 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.6 | 0.6 | GO:0071812 | regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
0.6 | 9.9 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.6 | 1.7 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.6 | 1.7 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.6 | 2.8 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.6 | 2.8 | GO:0036369 | transcription factor catabolic process(GO:0036369) |
0.6 | 2.2 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.6 | 1.7 | GO:0006742 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
0.5 | 3.8 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
0.5 | 0.5 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
0.5 | 4.4 | GO:0032484 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.5 | 0.5 | GO:1904000 | positive regulation of eating behavior(GO:1904000) |
0.5 | 1.6 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
0.5 | 1.0 | GO:0032764 | negative regulation of mast cell cytokine production(GO:0032764) |
0.5 | 1.5 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.5 | 2.5 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.5 | 7.9 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.5 | 1.0 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.5 | 2.0 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
0.5 | 1.5 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.5 | 1.9 | GO:0061347 | chemoattraction of serotonergic neuron axon(GO:0036517) planar cell polarity pathway involved in outflow tract morphogenesis(GO:0061347) planar cell polarity pathway involved in ventricular septum morphogenesis(GO:0061348) planar cell polarity pathway involved in cardiac right atrium morphogenesis(GO:0061349) planar cell polarity pathway involved in cardiac muscle tissue morphogenesis(GO:0061350) planar cell polarity pathway involved in pericardium morphogenesis(GO:0061354) chemoattraction of axon(GO:0061642) negative regulation of cell proliferation in midbrain(GO:1904934) planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation(GO:1904955) |
0.5 | 1.9 | GO:2001162 | regulation of histone H3-K79 methylation(GO:2001160) positive regulation of histone H3-K79 methylation(GO:2001162) |
0.5 | 0.5 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.5 | 2.9 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.5 | 1.9 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.5 | 1.9 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.5 | 17.3 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.5 | 2.3 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.5 | 3.2 | GO:0045229 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
0.5 | 2.8 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.5 | 1.4 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) negative regulation of lamellipodium organization(GO:1902744) |
0.5 | 2.7 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.5 | 4.1 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.5 | 1.4 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.5 | 0.5 | GO:0071030 | nuclear mRNA surveillance of spliceosomal pre-mRNA splicing(GO:0071030) nuclear retention of unspliced pre-mRNA at the site of transcription(GO:0071048) |
0.5 | 1.4 | GO:0003147 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) |
0.5 | 0.9 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.4 | 7.6 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.4 | 2.2 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.4 | 1.3 | GO:0007439 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
0.4 | 2.6 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.4 | 2.6 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.4 | 2.6 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.4 | 1.7 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.4 | 1.7 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.4 | 1.3 | GO:0006043 | glucosamine catabolic process(GO:0006043) |
0.4 | 2.6 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.4 | 7.6 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.4 | 3.0 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.4 | 2.5 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.4 | 3.8 | GO:0039533 | regulation of MDA-5 signaling pathway(GO:0039533) |
0.4 | 1.7 | GO:0010983 | positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
0.4 | 1.2 | GO:0097018 | renal albumin absorption(GO:0097018) regulation of renal albumin absorption(GO:2000532) |
0.4 | 3.7 | GO:0043622 | cortical microtubule organization(GO:0043622) |
0.4 | 3.7 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.4 | 1.6 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.4 | 4.9 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
0.4 | 1.2 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
0.4 | 2.4 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.4 | 0.8 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.4 | 0.8 | GO:1900154 | regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
0.4 | 1.5 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
0.4 | 0.8 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.4 | 0.8 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.4 | 2.7 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
0.4 | 27.3 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.4 | 4.2 | GO:0002084 | protein depalmitoylation(GO:0002084) |
0.4 | 7.1 | GO:0014894 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.4 | 2.2 | GO:0032625 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
0.4 | 3.3 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.4 | 1.8 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.4 | 1.1 | GO:0060057 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.4 | 1.1 | GO:0002384 | hepatic immune response(GO:0002384) |
0.4 | 1.4 | GO:0002238 | response to molecule of fungal origin(GO:0002238) cellular response to molecule of fungal origin(GO:0071226) |
0.4 | 2.5 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.4 | 0.7 | GO:1990502 | dense core granule maturation(GO:1990502) |
0.4 | 7.0 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.4 | 4.2 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.4 | 2.1 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.4 | 1.1 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
0.3 | 2.1 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.3 | 2.8 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.3 | 0.3 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.3 | 1.0 | GO:1902559 | 3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
0.3 | 6.2 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.3 | 1.7 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.3 | 1.4 | GO:0061582 | intestinal epithelial cell migration(GO:0061582) |
0.3 | 2.0 | GO:1902045 | negative regulation of Fas signaling pathway(GO:1902045) |
0.3 | 5.4 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.3 | 3.7 | GO:0018377 | protein myristoylation(GO:0018377) |
0.3 | 2.0 | GO:0036111 | very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
0.3 | 2.0 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.3 | 2.3 | GO:0050684 | regulation of mRNA processing(GO:0050684) |
0.3 | 2.9 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.3 | 2.9 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.3 | 4.5 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.3 | 1.3 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.3 | 0.3 | GO:0060142 | positive regulation of myotube differentiation(GO:0010831) regulation of syncytium formation by plasma membrane fusion(GO:0060142) positive regulation of syncytium formation by plasma membrane fusion(GO:0060143) regulation of myoblast fusion(GO:1901739) positive regulation of myoblast fusion(GO:1901741) |
0.3 | 0.6 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.3 | 4.1 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.3 | 1.3 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.3 | 1.3 | GO:0044053 | translocation of peptides or proteins into host(GO:0042000) translocation of peptides or proteins into host cell cytoplasm(GO:0044053) translocation of molecules into host(GO:0044417) translocation of peptides or proteins into other organism involved in symbiotic interaction(GO:0051808) translocation of molecules into other organism involved in symbiotic interaction(GO:0051836) |
0.3 | 1.6 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) |
0.3 | 3.8 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.3 | 1.3 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.3 | 2.5 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.3 | 1.2 | GO:0060178 | regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
0.3 | 2.5 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.3 | 0.3 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.3 | 0.9 | GO:0061485 | memory T cell proliferation(GO:0061485) |
0.3 | 2.4 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.3 | 2.4 | GO:1901189 | positive regulation of ephrin receptor signaling pathway(GO:1901189) positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
0.3 | 0.3 | GO:0032641 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
0.3 | 6.6 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.3 | 0.9 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.3 | 1.2 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
0.3 | 1.2 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.3 | 5.9 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.3 | 2.0 | GO:1902164 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
0.3 | 0.9 | GO:0061193 | sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
0.3 | 1.5 | GO:2000845 | testosterone secretion(GO:0035936) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
0.3 | 0.9 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.3 | 1.5 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.3 | 1.4 | GO:0060005 | vestibular reflex(GO:0060005) |
0.3 | 1.7 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.3 | 1.4 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.3 | 2.2 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
0.3 | 1.1 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
0.3 | 1.9 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.3 | 2.5 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.3 | 1.6 | GO:1901906 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.3 | 0.5 | GO:0015798 | myo-inositol transport(GO:0015798) |
0.3 | 0.8 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.3 | 2.5 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
0.3 | 0.8 | GO:0097198 | histone H3-K36 trimethylation(GO:0097198) |
0.3 | 0.3 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.3 | 0.8 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
0.3 | 1.1 | GO:0097475 | motor neuron migration(GO:0097475) |
0.3 | 0.5 | GO:0002090 | regulation of receptor internalization(GO:0002090) |
0.3 | 2.4 | GO:0000023 | maltose metabolic process(GO:0000023) |
0.3 | 2.7 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.3 | 1.6 | GO:0030578 | PML body organization(GO:0030578) |
0.3 | 1.6 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.3 | 15.5 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.3 | 0.8 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.3 | 1.1 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.3 | 1.1 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
0.3 | 1.8 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
0.3 | 1.3 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.3 | 2.3 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.3 | 2.6 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.3 | 0.8 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.3 | 1.5 | GO:0033489 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
0.3 | 10.4 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.2 | 2.2 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.2 | 0.7 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.2 | 1.2 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.2 | 9.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.2 | 0.5 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.2 | 1.2 | GO:0071427 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.2 | 7.3 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.2 | 13.1 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.2 | 1.0 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.2 | 1.9 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.2 | 0.5 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
0.2 | 4.0 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.2 | 2.4 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.2 | 5.0 | GO:0007172 | signal complex assembly(GO:0007172) |
0.2 | 3.8 | GO:0015074 | DNA integration(GO:0015074) |
0.2 | 1.7 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.2 | 0.5 | GO:0042704 | uterine wall breakdown(GO:0042704) |
0.2 | 0.5 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.2 | 0.5 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.2 | 0.9 | GO:0060992 | response to fungicide(GO:0060992) |
0.2 | 2.5 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.2 | 1.2 | GO:0021622 | optic cup structural organization(GO:0003409) oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
0.2 | 5.5 | GO:2000404 | regulation of T cell migration(GO:2000404) |
0.2 | 1.1 | GO:0035802 | adrenal cortex development(GO:0035801) adrenal cortex formation(GO:0035802) |
0.2 | 1.1 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.2 | 0.9 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.2 | 0.9 | GO:0035627 | ceramide transport(GO:0035627) |
0.2 | 3.2 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.2 | 0.7 | GO:0032796 | uropod organization(GO:0032796) |
0.2 | 1.8 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.2 | 2.2 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
0.2 | 0.4 | GO:1903365 | regulation of fear response(GO:1903365) regulation of behavioral fear response(GO:2000822) |
0.2 | 4.0 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.2 | 1.6 | GO:0000432 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
0.2 | 3.8 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.2 | 0.7 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.2 | 3.1 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.2 | 3.7 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.2 | 3.3 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.2 | 0.9 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.2 | 2.0 | GO:0070459 | prolactin secretion(GO:0070459) |
0.2 | 0.7 | GO:0031297 | replication fork processing(GO:0031297) |
0.2 | 4.8 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.2 | 1.1 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.2 | 3.4 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.2 | 1.7 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.2 | 1.3 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.2 | 5.2 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.2 | 0.4 | GO:0072695 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.2 | 0.6 | GO:0006433 | prolyl-tRNA aminoacylation(GO:0006433) |
0.2 | 0.8 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.2 | 1.4 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.2 | 3.7 | GO:0015816 | glycine transport(GO:0015816) |
0.2 | 2.6 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.2 | 0.8 | GO:0097045 | phosphatidylserine exposure on blood platelet(GO:0097045) |
0.2 | 0.8 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.2 | 1.0 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.2 | 0.8 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.2 | 1.2 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.2 | 0.8 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.2 | 1.2 | GO:0036302 | atrioventricular canal development(GO:0036302) |
0.2 | 1.0 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.2 | 3.5 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.2 | 0.8 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.2 | 1.3 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.2 | 1.1 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.2 | 0.4 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.2 | 0.9 | GO:0036324 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
0.2 | 1.1 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.2 | 0.6 | GO:0061010 | external genitalia morphogenesis(GO:0035261) gall bladder development(GO:0061010) |
0.2 | 1.5 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.2 | 1.1 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.2 | 7.1 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.2 | 3.9 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.2 | 0.2 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.2 | 1.1 | GO:1900114 | positive regulation of histone H3-K9 trimethylation(GO:1900114) |
0.2 | 0.9 | GO:1903921 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) protein processing in phagocytic vesicle(GO:1900756) regulation of plasma membrane raft polarization(GO:1903906) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
0.2 | 1.7 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.2 | 2.2 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.2 | 2.2 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.2 | 0.4 | GO:2000570 | T-helper 2 cell activation(GO:0035712) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
0.2 | 0.7 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.2 | 0.9 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.2 | 0.7 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.2 | 3.2 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.2 | 0.5 | GO:1902822 | lysosomal membrane organization(GO:0097212) regulation of late endosome to lysosome transport(GO:1902822) positive regulation of late endosome to lysosome transport(GO:1902824) |
0.2 | 3.4 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.2 | 0.9 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.2 | 1.2 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.2 | 1.2 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
0.2 | 1.2 | GO:0006196 | AMP catabolic process(GO:0006196) |
0.2 | 0.5 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.2 | 0.7 | GO:0016334 | morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
0.2 | 0.5 | GO:0036215 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.2 | 1.4 | GO:0060174 | limb bud formation(GO:0060174) |
0.2 | 1.5 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.2 | 0.9 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.2 | 1.4 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.2 | 3.4 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.2 | 2.0 | GO:0099639 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) neurotransmitter receptor transport, endosome to plasma membrane(GO:0099639) |
0.2 | 0.5 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.2 | 0.5 | GO:0051389 | inactivation of MAPKK activity(GO:0051389) |
0.2 | 1.3 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
0.2 | 4.1 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.2 | 3.9 | GO:0001502 | cartilage condensation(GO:0001502) |
0.2 | 1.1 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.2 | 1.5 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.2 | 1.3 | GO:0044782 | cilium organization(GO:0044782) |
0.2 | 4.2 | GO:0034063 | stress granule assembly(GO:0034063) |
0.2 | 0.2 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.2 | 5.3 | GO:0036065 | fucosylation(GO:0036065) |
0.2 | 0.6 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.2 | 1.9 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.2 | 1.6 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
0.2 | 1.6 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.2 | 1.1 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.2 | 3.8 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.2 | 1.4 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.2 | 0.5 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.2 | 0.9 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.2 | 2.3 | GO:0015871 | choline transport(GO:0015871) |
0.2 | 0.6 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.2 | 0.5 | GO:0071674 | mononuclear cell migration(GO:0071674) regulation of mononuclear cell migration(GO:0071675) |
0.2 | 3.5 | GO:0060004 | reflex(GO:0060004) |
0.2 | 0.8 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.2 | 0.2 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.2 | 2.0 | GO:0043201 | response to leucine(GO:0043201) |
0.1 | 0.7 | GO:0070943 | neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) neutrophil mediated killing of bacterium(GO:0070944) neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.1 | 0.3 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
0.1 | 1.6 | GO:1903351 | response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
0.1 | 1.2 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
0.1 | 2.2 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.9 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.1 | 0.4 | GO:0097484 | dendrite extension(GO:0097484) |
0.1 | 0.4 | GO:0072737 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
0.1 | 0.1 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.1 | 2.2 | GO:0044351 | macropinocytosis(GO:0044351) |
0.1 | 1.9 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.1 | 2.6 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.1 | 0.4 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
0.1 | 0.6 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
0.1 | 4.2 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 1.6 | GO:0031346 | positive regulation of cell projection organization(GO:0031346) |
0.1 | 0.4 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.1 | 0.3 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.1 | 1.1 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.1 | 4.2 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.1 | 0.6 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.1 | 0.7 | GO:2000690 | regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
0.1 | 1.8 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.1 | 1.8 | GO:2000680 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
0.1 | 2.3 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.1 | 1.2 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.1 | 1.1 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.1 | 0.5 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.1 | 2.3 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.1 | 1.2 | GO:0051665 | membrane raft localization(GO:0051665) |
0.1 | 1.3 | GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent(GO:0002479) |
0.1 | 0.8 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
0.1 | 0.1 | GO:0014717 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) skeletal muscle satellite cell activation(GO:0014719) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.1 | 0.9 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.1 | 0.4 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 | 0.1 | GO:2000209 | regulation of anoikis(GO:2000209) |
0.1 | 0.5 | GO:1902530 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
0.1 | 6.4 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.1 | 0.3 | GO:0043634 | polyadenylation-dependent RNA catabolic process(GO:0043633) polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
0.1 | 0.5 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.1 | 6.1 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.1 | 0.7 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.1 | 0.9 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.1 | 0.5 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.1 | 0.4 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
0.1 | 0.8 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.1 | 0.6 | GO:0006051 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
0.1 | 1.0 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 0.5 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.1 | 1.6 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.1 | 3.5 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.1 | 0.1 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
0.1 | 0.2 | GO:0032439 | endosome localization(GO:0032439) |
0.1 | 0.2 | GO:0071284 | cellular response to lead ion(GO:0071284) |
0.1 | 0.7 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.1 | 1.1 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.1 | 1.3 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.1 | 1.2 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.1 | 0.5 | GO:1904688 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.1 | 5.2 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.7 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.1 | 0.6 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
0.1 | 0.6 | GO:0048104 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) midbrain morphogenesis(GO:1904693) |
0.1 | 0.6 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
0.1 | 1.2 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.1 | 0.6 | GO:0009597 | detection of virus(GO:0009597) |
0.1 | 0.5 | GO:0018283 | metal incorporation into metallo-sulfur cluster(GO:0018282) iron incorporation into metallo-sulfur cluster(GO:0018283) |
0.1 | 0.3 | GO:1904796 | regulation of core promoter binding(GO:1904796) positive regulation of core promoter binding(GO:1904798) |
0.1 | 0.3 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
0.1 | 1.3 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.2 | GO:0060434 | bronchus morphogenesis(GO:0060434) |
0.1 | 0.5 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
0.1 | 0.3 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
0.1 | 1.2 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.1 | 0.9 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 2.7 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.1 | 0.7 | GO:0043126 | regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
0.1 | 0.2 | GO:0031344 | regulation of cell projection organization(GO:0031344) |
0.1 | 0.2 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.1 | 0.3 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.1 | 0.2 | GO:1902623 | negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
0.1 | 0.9 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.1 | 7.1 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
0.1 | 0.6 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 1.4 | GO:0048820 | hair follicle maturation(GO:0048820) |
0.1 | 0.9 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 0.6 | GO:0019541 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate metabolic process(GO:0019541) propionate biosynthetic process(GO:0019542) |
0.1 | 0.5 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.1 | 0.3 | GO:0031214 | biomineral tissue development(GO:0031214) |
0.1 | 1.4 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.1 | 2.3 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.1 | 0.2 | GO:0009609 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
0.1 | 2.2 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 0.1 | GO:0046833 | positive regulation of RNA export from nucleus(GO:0046833) |
0.1 | 0.5 | GO:0071344 | diphosphate metabolic process(GO:0071344) |
0.1 | 0.3 | GO:0032466 | abscission(GO:0009838) negative regulation of cytokinesis(GO:0032466) mitotic cytokinesis checkpoint(GO:0044878) |
0.1 | 0.4 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.5 | GO:1904383 | response to sodium phosphate(GO:1904383) |
0.1 | 2.8 | GO:0042554 | superoxide anion generation(GO:0042554) |
0.1 | 0.8 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.1 | 0.4 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.1 | 3.1 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 0.1 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.1 | 3.3 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.1 | 1.2 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.1 | 3.5 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.1 | 0.9 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.1 | 1.2 | GO:2000580 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.1 | 0.4 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.1 | 0.4 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.1 | 1.9 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.1 | 0.5 | GO:0036079 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
0.1 | 0.6 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 0.2 | GO:0071351 | interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
0.1 | 0.6 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.1 | 0.9 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.8 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.1 | 3.5 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.1 | 2.6 | GO:0097186 | amelogenesis(GO:0097186) |
0.1 | 1.1 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
0.1 | 1.2 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 0.3 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.1 | 6.3 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 0.3 | GO:0046416 | alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) D-amino acid metabolic process(GO:0046416) |
0.1 | 3.5 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.1 | 3.9 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.1 | 0.3 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
0.1 | 0.8 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.1 | 1.9 | GO:0002021 | response to dietary excess(GO:0002021) |
0.1 | 0.5 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.1 | 0.2 | GO:0048690 | regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
0.1 | 0.7 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.1 | 0.3 | GO:0072356 | chromosome passenger complex localization to kinetochore(GO:0072356) |
0.1 | 0.6 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.1 | 1.4 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
0.1 | 0.8 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 1.0 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.1 | 0.1 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.1 | 0.4 | GO:1901993 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) |
0.1 | 0.9 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.6 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
0.1 | 1.3 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.1 | 1.9 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.4 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.1 | 0.3 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
0.1 | 4.8 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
0.1 | 1.3 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.1 | 0.6 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.1 | 3.3 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 0.7 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.1 | 0.4 | GO:0060151 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
0.1 | 0.4 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.1 | 3.6 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.1 | 0.8 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 0.5 | GO:0032526 | response to retinoic acid(GO:0032526) |
0.1 | 0.3 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.1 | 0.4 | GO:0035900 | response to isolation stress(GO:0035900) |
0.1 | 0.1 | GO:0006424 | glutamyl-tRNA aminoacylation(GO:0006424) |
0.1 | 2.8 | GO:0003016 | respiratory system process(GO:0003016) |
0.1 | 6.2 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.1 | 1.0 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
0.1 | 2.3 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.3 | GO:0010824 | regulation of centrosome duplication(GO:0010824) |
0.1 | 1.0 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.1 | 0.3 | GO:0032212 | positive regulation of telomere maintenance via telomerase(GO:0032212) |
0.1 | 1.2 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.8 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
0.1 | 0.8 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.1 | 5.0 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 2.1 | GO:0048538 | thymus development(GO:0048538) |
0.1 | 0.7 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
0.1 | 0.8 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 1.1 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.1 | 0.5 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.1 | 0.2 | GO:0070377 | regulation of ERK5 cascade(GO:0070376) negative regulation of ERK5 cascade(GO:0070377) |
0.1 | 0.7 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
0.1 | 0.2 | GO:0090049 | regulation of cell migration involved in sprouting angiogenesis(GO:0090049) negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.1 | 1.6 | GO:0043647 | inositol phosphate metabolic process(GO:0043647) |
0.1 | 0.2 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
0.1 | 1.0 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.1 | 1.8 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 | 2.3 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.1 | 6.4 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 0.5 | GO:0051149 | positive regulation of muscle cell differentiation(GO:0051149) |
0.1 | 0.4 | GO:0051549 | positive regulation of keratinocyte migration(GO:0051549) |
0.1 | 0.3 | GO:2000490 | negative regulation of hepatic stellate cell activation(GO:2000490) |
0.1 | 0.4 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.1 | 0.5 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
0.1 | 0.4 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
0.1 | 1.0 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.1 | 1.1 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.1 | 1.4 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.1 | 0.1 | GO:0070602 | regulation of centromeric sister chromatid cohesion(GO:0070602) |
0.1 | 3.2 | GO:1901998 | toxin transport(GO:1901998) |
0.1 | 1.3 | GO:0042737 | drug catabolic process(GO:0042737) |
0.1 | 0.2 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.1 | 1.1 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.1 | 0.3 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.1 | 0.1 | GO:0070560 | protein secretion by platelet(GO:0070560) |
0.1 | 0.2 | GO:1902473 | regulation of protein localization to synapse(GO:1902473) |
0.1 | 0.3 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.1 | 1.8 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
0.1 | 1.4 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.1 | 0.7 | GO:0015825 | L-serine transport(GO:0015825) |
0.1 | 1.7 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.1 | 0.3 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
0.1 | 0.4 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
0.1 | 0.5 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.1 | 0.1 | GO:0050766 | positive regulation of phagocytosis(GO:0050766) |
0.1 | 1.1 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
0.1 | 0.1 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.1 | 0.3 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.1 | 0.1 | GO:0003158 | endothelium development(GO:0003158) |
0.1 | 0.7 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.5 | GO:0051697 | protein delipidation(GO:0051697) |
0.1 | 0.8 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.1 | 1.4 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.1 | 0.4 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.3 | GO:1904977 | lymphatic endothelial cell migration(GO:1904977) |
0.1 | 0.5 | GO:0061756 | leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.1 | 2.2 | GO:0015991 | ATP hydrolysis coupled proton transport(GO:0015991) |
0.1 | 0.2 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.1 | 0.2 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) |
0.1 | 0.6 | GO:0051216 | cartilage development(GO:0051216) |
0.1 | 0.1 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
0.1 | 0.3 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.1 | 0.7 | GO:0009306 | protein secretion(GO:0009306) |
0.1 | 1.0 | GO:0002320 | lymphoid progenitor cell differentiation(GO:0002320) |
0.1 | 3.3 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 0.2 | GO:0035508 | positive regulation of myosin-light-chain-phosphatase activity(GO:0035508) |
0.1 | 0.3 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
0.1 | 0.8 | GO:0060039 | pericardium development(GO:0060039) |
0.1 | 2.5 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.1 | 0.1 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
0.1 | 0.3 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.1 | 0.1 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.1 | 0.6 | GO:0032876 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.1 | 0.6 | GO:0003374 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
0.1 | 0.6 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
0.1 | 1.8 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.1 | 0.8 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 0.8 | GO:1904896 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
0.1 | 0.2 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.1 | 0.7 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.1 | 0.4 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.1 | 0.3 | GO:0043335 | protein unfolding(GO:0043335) |
0.1 | 0.9 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.3 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.4 | GO:0051176 | positive regulation of sulfur metabolic process(GO:0051176) |
0.1 | 0.9 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
0.1 | 2.1 | GO:0042730 | fibrinolysis(GO:0042730) |
0.1 | 1.0 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.1 | 0.4 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 1.0 | GO:0072189 | ureter development(GO:0072189) |
0.1 | 0.2 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.1 | 0.5 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.1 | 0.2 | GO:1903147 | negative regulation of macromitophagy(GO:1901525) negative regulation of mitophagy(GO:1903147) |
0.1 | 4.9 | GO:0001895 | retina homeostasis(GO:0001895) |
0.1 | 0.5 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 1.1 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.1 | 5.1 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.1 | 0.1 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.1 | 0.5 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.1 | 1.6 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.1 | 1.0 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.1 | 1.3 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 1.0 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 1.5 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 1.0 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.1 | 2.0 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
0.1 | 1.1 | GO:0060135 | maternal process involved in female pregnancy(GO:0060135) |
0.1 | 0.6 | GO:0060453 | regulation of gastric acid secretion(GO:0060453) |
0.1 | 0.9 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
0.1 | 0.7 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.1 | 0.2 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.1 | 0.3 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.1 | 0.5 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.1 | 1.0 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
0.1 | 0.4 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.1 | 0.4 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.1 | 2.0 | GO:0018279 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 0.2 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 0.8 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.0 | 0.7 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.0 | GO:0002583 | regulation of antigen processing and presentation of peptide antigen(GO:0002583) |
0.0 | 0.3 | GO:0090494 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.0 | 0.4 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.0 | 1.0 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.0 | 1.1 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.0 | 0.9 | GO:0050942 | positive regulation of pigment cell differentiation(GO:0050942) |
0.0 | 0.2 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.2 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.0 | 0.2 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.0 | 0.2 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.0 | 0.2 | GO:0060560 | developmental growth involved in morphogenesis(GO:0060560) neuron projection extension(GO:1990138) |
0.0 | 0.4 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.0 | 0.3 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.0 | 0.3 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
0.0 | 1.4 | GO:0006482 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.0 | 0.5 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.0 | 0.4 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.2 | GO:0021779 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.0 | 0.4 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
0.0 | 1.1 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.0 | 0.6 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.0 | 1.0 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.0 | 0.2 | GO:0001706 | endoderm formation(GO:0001706) |
0.0 | 1.1 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.0 | 0.1 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.0 | 0.9 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.0 | 0.4 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.0 | 0.4 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.0 | 0.1 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
0.0 | 0.3 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
0.0 | 0.2 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
0.0 | 0.2 | GO:0060021 | palate development(GO:0060021) |
0.0 | 0.4 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.1 | GO:0060345 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) spleen trabecula formation(GO:0060345) iron cation export(GO:1903414) ferrous iron export(GO:1903988) |
0.0 | 0.3 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.0 | 0.2 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
0.0 | 0.5 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
0.0 | 0.9 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.0 | 0.6 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.9 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.0 | 0.3 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.0 | 0.2 | GO:0090156 | cellular sphingolipid homeostasis(GO:0090156) |
0.0 | 0.2 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.0 | 4.1 | GO:0006903 | vesicle targeting(GO:0006903) |
0.0 | 0.2 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.0 | 0.1 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.0 | 0.3 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.0 | 1.4 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.0 | 0.1 | GO:0045554 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
0.0 | 0.3 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.0 | 0.0 | GO:0007620 | insemination(GO:0007320) copulation(GO:0007620) |
0.0 | 0.3 | GO:0070163 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) negative regulation of adiponectin secretion(GO:0070164) |
0.0 | 1.8 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.0 | 2.9 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.0 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.0 | 0.9 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.0 | 0.3 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 0.2 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.0 | 1.1 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.0 | 0.1 | GO:0015883 | FAD transport(GO:0015883) FAD transmembrane transport(GO:0035350) |
0.0 | 0.4 | GO:1904874 | positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
0.0 | 1.3 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 0.1 | GO:0033320 | UDP-D-xylose metabolic process(GO:0033319) UDP-D-xylose biosynthetic process(GO:0033320) |
0.0 | 0.2 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.0 | 0.1 | GO:1900044 | regulation of protein K63-linked ubiquitination(GO:1900044) |
0.0 | 0.4 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.0 | 0.0 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.0 | 0.2 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.0 | 2.0 | GO:0051058 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.0 | 0.8 | GO:0035411 | catenin import into nucleus(GO:0035411) |
0.0 | 0.3 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.0 | 0.4 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.0 | 1.3 | GO:0042992 | negative regulation of transcription factor import into nucleus(GO:0042992) |
0.0 | 0.4 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.0 | 0.1 | GO:0040033 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.0 | 0.3 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.0 | 2.4 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.6 | GO:0034763 | negative regulation of transmembrane transport(GO:0034763) |
0.0 | 0.1 | GO:0042214 | terpene metabolic process(GO:0042214) |
0.0 | 0.6 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.5 | GO:0009642 | response to light intensity(GO:0009642) |
0.0 | 0.3 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.0 | 0.8 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.0 | 0.1 | GO:0033594 | response to hydroxyisoflavone(GO:0033594) |
0.0 | 0.3 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 1.0 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
0.0 | 0.1 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.0 | 0.3 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.0 | 1.7 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.0 | 0.2 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.0 | 1.1 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.0 | 0.5 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.0 | 0.2 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.0 | 1.0 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
0.0 | 0.8 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.1 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.0 | 0.7 | GO:1902001 | fatty acid transmembrane transport(GO:1902001) |
0.0 | 0.1 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.0 | 0.4 | GO:0090220 | chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
0.0 | 0.6 | GO:0016101 | retinoid metabolic process(GO:0001523) diterpenoid metabolic process(GO:0016101) |
0.0 | 0.1 | GO:0000706 | meiotic DNA double-strand break processing(GO:0000706) |
0.0 | 0.1 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
0.0 | 0.7 | GO:0007173 | epidermal growth factor receptor signaling pathway(GO:0007173) |
0.0 | 0.1 | GO:0006983 | ER overload response(GO:0006983) |
0.0 | 0.1 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.0 | 0.8 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.0 | 0.1 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.0 | 0.2 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.0 | 1.0 | GO:0090278 | negative regulation of peptide secretion(GO:0002792) negative regulation of insulin secretion(GO:0046676) negative regulation of peptide hormone secretion(GO:0090278) |
0.0 | 0.1 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.0 | 0.6 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.0 | 0.1 | GO:0030207 | chondroitin sulfate catabolic process(GO:0030207) |
0.0 | 0.4 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.0 | 0.1 | GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
0.0 | 0.1 | GO:0061015 | snRNA import into nucleus(GO:0061015) |
0.0 | 0.8 | GO:0014032 | neural crest cell development(GO:0014032) |
0.0 | 0.3 | GO:0036344 | platelet formation(GO:0030220) platelet morphogenesis(GO:0036344) |
0.0 | 0.8 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.0 | 0.3 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.0 | 0.3 | GO:0006477 | protein sulfation(GO:0006477) |
0.0 | 0.1 | GO:1904117 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
0.0 | 0.1 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.0 | 0.8 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.0 | 0.2 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.0 | 3.1 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.2 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.0 | 0.3 | GO:2000146 | negative regulation of cell motility(GO:2000146) |
0.0 | 0.4 | GO:0050832 | defense response to fungus(GO:0050832) |
0.0 | 0.4 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.0 | 0.2 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.1 | GO:0038170 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
0.0 | 0.5 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.0 | 0.3 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.0 | 2.4 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.2 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.0 | 0.4 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.0 | 0.2 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.0 | 0.4 | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) |
0.0 | 0.3 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.2 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.0 | GO:0002877 | acute inflammatory response to non-antigenic stimulus(GO:0002525) regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
0.0 | 0.5 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.2 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.0 | 0.6 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.0 | 1.4 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.0 | 0.2 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
0.0 | 0.0 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.0 | 0.5 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.0 | 0.6 | GO:0050918 | positive chemotaxis(GO:0050918) |
0.0 | 0.2 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.0 | 0.2 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.0 | 0.6 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
0.0 | 1.3 | GO:0030049 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
0.0 | 0.2 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.0 | 0.3 | GO:0042220 | response to cocaine(GO:0042220) |
0.0 | 0.2 | GO:0042749 | regulation of circadian sleep/wake cycle(GO:0042749) |
0.0 | 0.3 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.0 | 0.4 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.0 | 0.0 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.0 | 0.1 | GO:0046851 | negative regulation of bone resorption(GO:0045779) negative regulation of bone remodeling(GO:0046851) |
0.0 | 1.3 | GO:0009301 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.0 | 0.0 | GO:0098507 | polynucleotide 5' dephosphorylation(GO:0098507) |
0.0 | 0.1 | GO:0003339 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003339) |
0.0 | 0.5 | GO:0006306 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.0 | 0.1 | GO:1900409 | positive regulation of cellular response to oxidative stress(GO:1900409) positive regulation of response to oxidative stress(GO:1902884) |
0.0 | 0.3 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.1 | GO:0014904 | myotube cell development(GO:0014904) |
0.0 | 0.2 | GO:0060325 | face morphogenesis(GO:0060325) |
0.0 | 0.1 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.1 | GO:0090410 | malonate catabolic process(GO:0090410) |
0.0 | 0.1 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.0 | 0.2 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.0 | 0.3 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.0 | 0.4 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.0 | 0.3 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.0 | 0.6 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.6 | GO:0003341 | cilium movement(GO:0003341) |
0.0 | 0.1 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.0 | 0.2 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.0 | 0.1 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.1 | GO:0046785 | microtubule polymerization(GO:0046785) |
0.0 | 0.3 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.0 | 0.1 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) |
0.0 | 0.1 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.0 | 0.0 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.0 | 0.2 | GO:0031648 | protein destabilization(GO:0031648) |
0.0 | 0.1 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.0 | 0.4 | GO:0035722 | interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
0.0 | 0.1 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.0 | 0.1 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 5.1 | GO:0072563 | endothelial microparticle(GO:0072563) |
1.3 | 16.0 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
1.3 | 7.5 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
1.1 | 9.1 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
1.1 | 1.1 | GO:0030689 | Noc complex(GO:0030689) |
0.9 | 2.6 | GO:1990393 | 3M complex(GO:1990393) |
0.8 | 9.9 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.8 | 2.3 | GO:0070877 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
0.7 | 2.8 | GO:0071020 | post-spliceosomal complex(GO:0071020) |
0.6 | 2.6 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
0.6 | 2.5 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.6 | 6.0 | GO:0032010 | phagolysosome(GO:0032010) |
0.6 | 1.8 | GO:0005595 | collagen type XII trimer(GO:0005595) |
0.5 | 2.2 | GO:0097342 | ripoptosome(GO:0097342) |
0.5 | 2.0 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
0.5 | 3.0 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.5 | 2.5 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
0.5 | 1.9 | GO:1990745 | EARP complex(GO:1990745) |
0.5 | 6.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.4 | 2.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.4 | 10.0 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.4 | 3.0 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.4 | 2.6 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.4 | 1.7 | GO:0031592 | centrosomal corona(GO:0031592) |
0.4 | 3.3 | GO:0070847 | core mediator complex(GO:0070847) |
0.4 | 3.3 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.4 | 2.8 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.4 | 4.9 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.4 | 29.8 | GO:0001533 | cornified envelope(GO:0001533) |
0.4 | 14.5 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.4 | 1.6 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.4 | 4.2 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.4 | 1.9 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.4 | 1.5 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.4 | 1.9 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.4 | 2.6 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.4 | 3.9 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.4 | 2.8 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.3 | 1.4 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.3 | 6.8 | GO:0070938 | contractile ring(GO:0070938) |
0.3 | 1.0 | GO:0000502 | proteasome complex(GO:0000502) |
0.3 | 2.3 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.3 | 1.3 | GO:0042587 | glycogen granule(GO:0042587) |
0.3 | 1.3 | GO:0034272 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
0.3 | 0.6 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
0.3 | 5.1 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.3 | 0.9 | GO:1990723 | cytoplasmic periphery of the nuclear pore complex(GO:1990723) |
0.3 | 1.9 | GO:0031673 | H zone(GO:0031673) |
0.3 | 6.0 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.3 | 3.0 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.3 | 12.4 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.3 | 1.8 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.3 | 0.9 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
0.3 | 6.8 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.3 | 1.1 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.3 | 2.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.3 | 3.6 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.3 | 0.3 | GO:0000346 | transcription export complex(GO:0000346) |
0.3 | 1.4 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.3 | 3.8 | GO:0030057 | desmosome(GO:0030057) |
0.3 | 0.8 | GO:0018444 | translation release factor complex(GO:0018444) |
0.3 | 1.9 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.3 | 1.6 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) |
0.3 | 13.9 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.3 | 0.8 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.3 | 0.8 | GO:0032783 | ELL-EAF complex(GO:0032783) |
0.3 | 0.5 | GO:0097227 | sperm annulus(GO:0097227) |
0.3 | 2.1 | GO:0070545 | PeBoW complex(GO:0070545) |
0.3 | 1.8 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.3 | 11.4 | GO:0097228 | sperm principal piece(GO:0097228) |
0.3 | 2.8 | GO:0071986 | Ragulator complex(GO:0071986) |
0.2 | 2.2 | GO:0098845 | postsynaptic endosome(GO:0098845) |
0.2 | 26.8 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.2 | 2.4 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 1.4 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.2 | 2.9 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.2 | 5.9 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.2 | 0.9 | GO:0070985 | TFIIK complex(GO:0070985) |
0.2 | 1.3 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.2 | 1.0 | GO:0032449 | CBM complex(GO:0032449) |
0.2 | 2.9 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.2 | 0.6 | GO:0005745 | m-AAA complex(GO:0005745) |
0.2 | 1.4 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.2 | 15.9 | GO:0002102 | podosome(GO:0002102) |
0.2 | 0.6 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.2 | 1.8 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.2 | 2.0 | GO:0055028 | cortical microtubule(GO:0055028) |
0.2 | 0.6 | GO:0033655 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
0.2 | 3.5 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.2 | 5.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.2 | 3.3 | GO:0005882 | intermediate filament(GO:0005882) |
0.2 | 1.9 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.2 | 1.3 | GO:0097427 | microtubule bundle(GO:0097427) |
0.2 | 0.8 | GO:0055087 | Ski complex(GO:0055087) |
0.2 | 1.3 | GO:1990130 | Iml1 complex(GO:1990130) |
0.2 | 1.1 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.2 | 2.6 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.2 | 3.2 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.2 | 3.9 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.2 | 0.5 | GO:0034515 | proteasome storage granule(GO:0034515) |
0.2 | 1.5 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 0.7 | GO:0045293 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
0.2 | 1.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.2 | 1.6 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
0.2 | 1.7 | GO:0005827 | polar microtubule(GO:0005827) |
0.2 | 18.7 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.2 | 2.2 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.2 | 0.5 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.2 | 0.5 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.2 | 1.2 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
0.2 | 5.4 | GO:0034706 | sodium channel complex(GO:0034706) |
0.2 | 2.0 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.2 | 1.1 | GO:0045298 | tubulin complex(GO:0045298) |
0.2 | 0.3 | GO:0097441 | basilar dendrite(GO:0097441) |
0.2 | 1.6 | GO:0030478 | actin cap(GO:0030478) |
0.2 | 0.8 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
0.2 | 6.2 | GO:0032156 | septin cytoskeleton(GO:0032156) |
0.2 | 0.3 | GO:0000229 | cytoplasmic chromosome(GO:0000229) |
0.2 | 3.7 | GO:0043203 | axon hillock(GO:0043203) |
0.2 | 18.4 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 1.9 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.1 | 10.6 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 2.4 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.1 | 3.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 2.2 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.4 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
0.1 | 1.7 | GO:0000322 | storage vacuole(GO:0000322) |
0.1 | 0.6 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 2.3 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 1.8 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 0.8 | GO:0035339 | SPOTS complex(GO:0035339) |
0.1 | 0.9 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.9 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.1 | 2.3 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.1 | 16.7 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 1.6 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 0.6 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 0.6 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
0.1 | 5.8 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 1.1 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 1.7 | GO:0097433 | dense body(GO:0097433) |
0.1 | 0.9 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.1 | 5.8 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.5 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.1 | 0.1 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.1 | 0.6 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 2.0 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 0.6 | GO:0005818 | astral microtubule(GO:0000235) aster(GO:0005818) |
0.1 | 1.0 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 2.8 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 2.9 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.1 | 1.8 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 8.3 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 2.8 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 1.0 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 2.6 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.1 | 0.7 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
0.1 | 22.6 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 1.1 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 2.2 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.5 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.1 | 1.0 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 2.3 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 0.7 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 0.3 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.1 | 1.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 0.8 | GO:0035976 | AP1 complex(GO:0035976) |
0.1 | 8.2 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.4 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 1.0 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 0.6 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 2.0 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 0.2 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 0.5 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 1.8 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 1.4 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 2.0 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 0.4 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.1 | 8.7 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.1 | 1.1 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.8 | GO:0000243 | commitment complex(GO:0000243) |
0.1 | 1.2 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 0.8 | GO:0072687 | meiotic spindle(GO:0072687) |
0.1 | 0.4 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 0.6 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.1 | 0.1 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 2.7 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.1 | 1.0 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.1 | 0.3 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.9 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 9.1 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.2 | GO:0042022 | interleukin-12 receptor complex(GO:0042022) |
0.1 | 0.8 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.1 | 0.6 | GO:0097413 | Lewy body(GO:0097413) |
0.1 | 0.4 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.1 | 35.0 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 0.9 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 1.0 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.2 | GO:0071159 | NF-kappaB complex(GO:0071159) |
0.1 | 0.5 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 0.4 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 3.7 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.1 | 1.2 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 3.1 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 0.4 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.4 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.7 | GO:0044433 | cytoplasmic vesicle part(GO:0044433) |
0.1 | 0.2 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.1 | 1.2 | GO:0005770 | late endosome(GO:0005770) |
0.1 | 0.3 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 2.7 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 0.3 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.1 | 0.2 | GO:0070931 | Golgi-associated vesicle lumen(GO:0070931) |
0.1 | 1.4 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.8 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 0.3 | GO:0017102 | methionyl glutamyl tRNA synthetase complex(GO:0017102) |
0.1 | 0.4 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.1 | 0.7 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 1.2 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 0.4 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.1 | 0.2 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.1 | 4.2 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 4.2 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.1 | 5.5 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.1 | 1.3 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.3 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
0.0 | 0.1 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.0 | 2.1 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.0 | 0.5 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.0 | 3.7 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.0 | 0.5 | GO:0030897 | HOPS complex(GO:0030897) |
0.0 | 0.5 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 1.3 | GO:0071564 | npBAF complex(GO:0071564) |
0.0 | 0.2 | GO:0072534 | perineuronal net(GO:0072534) |
0.0 | 3.0 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 1.0 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.0 | 0.1 | GO:0005602 | complement component C1 complex(GO:0005602) |
0.0 | 1.1 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.0 | 0.4 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 0.1 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.0 | 0.7 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.7 | GO:0005861 | troponin complex(GO:0005861) |
0.0 | 1.3 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.5 | GO:0005642 | annulate lamellae(GO:0005642) |
0.0 | 0.2 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.0 | 1.6 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 0.4 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.0 | 1.7 | GO:0030424 | axon(GO:0030424) |
0.0 | 0.8 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 0.3 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.0 | 0.4 | GO:0070187 | telosome(GO:0070187) |
0.0 | 3.1 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.0 | 0.4 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.0 | 0.2 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.2 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.0 | 0.3 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.0 | 0.2 | GO:0036019 | endolysosome(GO:0036019) |
0.0 | 0.2 | GO:0031310 | intrinsic component of endosome membrane(GO:0031302) intrinsic component of vacuolar membrane(GO:0031310) |
0.0 | 1.1 | GO:0031461 | cullin-RING ubiquitin ligase complex(GO:0031461) |
0.0 | 0.5 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.2 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
0.0 | 0.8 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 1.0 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.2 | GO:0031984 | organelle subcompartment(GO:0031984) |
0.0 | 0.5 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.5 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.3 | GO:0099738 | cell cortex region(GO:0099738) |
0.0 | 0.2 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 2.2 | GO:0030118 | clathrin coat(GO:0030118) |
0.0 | 0.3 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.2 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.0 | 0.5 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.0 | 0.1 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
0.0 | 0.3 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 0.4 | GO:0043195 | terminal bouton(GO:0043195) |
0.0 | 0.1 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.0 | 0.7 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.0 | 0.3 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.3 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.0 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.0 | 0.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 0.3 | GO:0031527 | filopodium membrane(GO:0031527) |
0.0 | 0.0 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 3.9 | GO:1904813 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
0.0 | 0.2 | GO:0097470 | ribbon synapse(GO:0097470) |
0.0 | 5.1 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.0 | 4.8 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 0.5 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.5 | GO:0045178 | basal part of cell(GO:0045178) |
0.0 | 0.7 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.0 | 2.0 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 1.9 | GO:0009986 | cell surface(GO:0009986) |
0.0 | 0.1 | GO:0044754 | autolysosome(GO:0044754) |
0.0 | 0.3 | GO:0036038 | MKS complex(GO:0036038) |
0.0 | 0.3 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.8 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 2.2 | GO:0070160 | occluding junction(GO:0070160) |
0.0 | 0.3 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.1 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.0 | 6.2 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.0 | 0.2 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.8 | GO:0035580 | specific granule lumen(GO:0035580) |
0.0 | 0.4 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 4.2 | GO:0005911 | cell-cell junction(GO:0005911) |
0.0 | 0.3 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 1.7 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.9 | GO:0036126 | sperm flagellum(GO:0036126) |
0.0 | 0.2 | GO:0032426 | stereocilium tip(GO:0032426) |
0.0 | 0.1 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
0.0 | 0.1 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.0 | 0.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.0 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.0 | 0.7 | GO:0030684 | preribosome(GO:0030684) |
0.0 | 0.1 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.0 | 1.3 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.2 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.1 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.1 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.2 | GO:0090544 | BAF-type complex(GO:0090544) |
0.0 | 0.6 | GO:0035579 | specific granule membrane(GO:0035579) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 6.4 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
1.9 | 7.7 | GO:1990175 | EH domain binding(GO:1990175) |
1.7 | 5.1 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
1.7 | 11.6 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
1.6 | 4.9 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
1.2 | 12.0 | GO:0004111 | creatine kinase activity(GO:0004111) |
1.1 | 5.5 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
1.1 | 2.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
1.0 | 3.1 | GO:0016768 | spermine synthase activity(GO:0016768) |
1.0 | 8.8 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.9 | 4.7 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
0.9 | 4.6 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
0.9 | 2.8 | GO:0000384 | first spliceosomal transesterification activity(GO:0000384) |
0.9 | 10.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.8 | 4.2 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.8 | 4.1 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
0.8 | 7.3 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.8 | 15.3 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.8 | 2.3 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.7 | 4.4 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.7 | 16.7 | GO:0015643 | toxic substance binding(GO:0015643) |
0.7 | 4.1 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) |
0.7 | 6.2 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.7 | 2.7 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.7 | 2.0 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
0.6 | 4.5 | GO:0001129 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
0.6 | 11.5 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.6 | 2.5 | GO:0098808 | mRNA cap binding(GO:0098808) |
0.6 | 2.5 | GO:0070052 | collagen V binding(GO:0070052) |
0.6 | 2.5 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.6 | 2.5 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.6 | 3.6 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.6 | 1.7 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.5 | 0.5 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
0.5 | 3.3 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.5 | 3.8 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.5 | 2.2 | GO:0035501 | MH1 domain binding(GO:0035501) |
0.5 | 2.6 | GO:0035500 | MH2 domain binding(GO:0035500) |
0.5 | 4.2 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.5 | 1.5 | GO:0061663 | NEDD8 ligase activity(GO:0061663) |
0.5 | 0.5 | GO:0031543 | peptidyl-proline dioxygenase activity(GO:0031543) |
0.5 | 0.5 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
0.5 | 1.9 | GO:1902379 | receptor tyrosine kinase-like orphan receptor binding(GO:0005115) chemoattractant activity involved in axon guidance(GO:1902379) |
0.5 | 7.2 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.5 | 5.2 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.5 | 1.9 | GO:0033823 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
0.5 | 3.8 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.5 | 3.3 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.5 | 5.6 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.5 | 1.4 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.5 | 1.8 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
0.5 | 7.7 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.4 | 3.6 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.4 | 2.7 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.4 | 3.9 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.4 | 3.0 | GO:0050733 | RS domain binding(GO:0050733) |
0.4 | 6.9 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.4 | 1.7 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.4 | 1.3 | GO:0004342 | glucosamine-6-phosphate deaminase activity(GO:0004342) |
0.4 | 7.4 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.4 | 6.5 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.4 | 2.8 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.4 | 1.2 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.4 | 3.1 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.4 | 2.3 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.4 | 2.3 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
0.4 | 1.5 | GO:0070704 | C-5 sterol desaturase activity(GO:0000248) sterol desaturase activity(GO:0070704) |
0.4 | 2.3 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.4 | 1.8 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.4 | 1.5 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.4 | 2.9 | GO:0035326 | enhancer binding(GO:0035326) |
0.4 | 1.1 | GO:0070538 | oleic acid binding(GO:0070538) |
0.4 | 1.1 | GO:0070119 | ciliary neurotrophic factor binding(GO:0070119) |
0.4 | 6.4 | GO:0008199 | ferric iron binding(GO:0008199) |
0.4 | 1.4 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.4 | 3.2 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.4 | 1.8 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
0.3 | 13.6 | GO:0017166 | vinculin binding(GO:0017166) |
0.3 | 1.0 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.3 | 1.0 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
0.3 | 1.0 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
0.3 | 7.9 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.3 | 4.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.3 | 3.4 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.3 | 1.4 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.3 | 2.0 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.3 | 2.0 | GO:0044594 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity(GO:0033989) 17-beta-hydroxysteroid dehydrogenase (NAD+) activity(GO:0044594) |
0.3 | 3.6 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.3 | 2.2 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.3 | 1.3 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.3 | 0.9 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.3 | 1.2 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.3 | 4.5 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.3 | 4.2 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.3 | 1.8 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.3 | 1.2 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.3 | 1.5 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.3 | 3.8 | GO:0097016 | L27 domain binding(GO:0097016) |
0.3 | 0.9 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.3 | 1.7 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.3 | 1.1 | GO:0036033 | mediator complex binding(GO:0036033) |
0.3 | 1.1 | GO:0010348 | lithium:proton antiporter activity(GO:0010348) |
0.3 | 1.4 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.3 | 19.0 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.3 | 12.6 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.3 | 1.6 | GO:0034431 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
0.3 | 4.6 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.3 | 5.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.3 | 1.6 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.3 | 2.4 | GO:0032450 | alpha-1,4-glucosidase activity(GO:0004558) maltose alpha-glucosidase activity(GO:0032450) |
0.3 | 2.9 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.3 | 1.1 | GO:0004040 | amidase activity(GO:0004040) |
0.3 | 0.8 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.3 | 0.8 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.3 | 3.7 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.3 | 1.3 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.3 | 2.1 | GO:0071253 | connexin binding(GO:0071253) |
0.3 | 2.3 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.3 | 2.3 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.3 | 1.5 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.3 | 1.3 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
0.3 | 3.5 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.3 | 3.8 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.2 | 0.7 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.2 | 3.0 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.2 | 36.3 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.2 | 0.7 | GO:0019961 | interferon binding(GO:0019961) |
0.2 | 3.7 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.2 | 1.7 | GO:0051022 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.2 | 7.1 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.2 | 2.4 | GO:0008565 | protein transporter activity(GO:0008565) |
0.2 | 3.4 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.2 | 1.2 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.2 | 2.4 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 3.1 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.2 | 0.7 | GO:0015130 | mevalonate transmembrane transporter activity(GO:0015130) |
0.2 | 0.5 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.2 | 0.9 | GO:0033765 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.2 | 2.5 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.2 | 0.2 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.2 | 1.6 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.2 | 0.7 | GO:0052856 | NADHX epimerase activity(GO:0052856) NADPHX epimerase activity(GO:0052857) |
0.2 | 2.9 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.2 | 0.7 | GO:0016652 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
0.2 | 0.9 | GO:0008184 | purine nucleobase binding(GO:0002060) glycogen phosphorylase activity(GO:0008184) |
0.2 | 4.6 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.2 | 4.0 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.2 | 2.2 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.2 | 1.7 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.2 | 1.7 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.2 | 0.6 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.2 | 0.6 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.2 | 1.3 | GO:0042806 | fucose binding(GO:0042806) |
0.2 | 1.1 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.2 | 1.9 | GO:0089720 | caspase binding(GO:0089720) |
0.2 | 6.6 | GO:0031402 | sodium ion binding(GO:0031402) |
0.2 | 7.0 | GO:0031489 | myosin V binding(GO:0031489) |
0.2 | 0.6 | GO:0004827 | proline-tRNA ligase activity(GO:0004827) |
0.2 | 1.0 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.2 | 4.3 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 5.1 | GO:0050700 | CARD domain binding(GO:0050700) |
0.2 | 3.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.2 | 0.6 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.2 | 0.6 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
0.2 | 1.2 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.2 | 0.4 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
0.2 | 0.6 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.2 | 10.5 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.2 | 0.8 | GO:0070728 | leucine binding(GO:0070728) |
0.2 | 0.9 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.2 | 1.7 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.2 | 2.0 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.2 | 0.5 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.2 | 2.1 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.2 | 0.4 | GO:0070513 | death domain binding(GO:0070513) |
0.2 | 1.6 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.2 | 1.2 | GO:0008481 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.2 | 1.4 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.2 | 1.0 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.2 | 4.9 | GO:0031005 | filamin binding(GO:0031005) |
0.2 | 1.7 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.2 | 1.4 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.2 | 0.5 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
0.2 | 1.6 | GO:0019798 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.2 | 2.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.2 | 1.5 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.2 | 1.7 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.2 | 1.9 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.2 | 5.6 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 2.5 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.2 | 1.7 | GO:0050693 | LBD domain binding(GO:0050693) |
0.2 | 2.0 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.2 | 0.8 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.2 | 1.7 | GO:0043515 | kinetochore binding(GO:0043515) |
0.2 | 3.6 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.2 | 1.3 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.2 | 0.8 | GO:0052829 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) inositol-1,3,4-trisphosphate 1-phosphatase activity(GO:0052829) |
0.2 | 1.8 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.2 | 2.1 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.2 | 0.6 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.2 | 0.6 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.2 | 0.6 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.2 | 2.4 | GO:0045159 | myosin II binding(GO:0045159) |
0.2 | 2.7 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.2 | 2.4 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.2 | 1.7 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
0.2 | 0.9 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.2 | 0.5 | GO:0031071 | cysteine desulfurase activity(GO:0031071) |
0.2 | 0.8 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.2 | 0.5 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
0.2 | 13.4 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.2 | 0.6 | GO:0052591 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
0.2 | 0.5 | GO:0030626 | U12 snRNA binding(GO:0030626) |
0.1 | 1.3 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
0.1 | 0.4 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
0.1 | 0.3 | GO:0016896 | exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
0.1 | 4.8 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.1 | 9.4 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 0.4 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
0.1 | 2.0 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 3.2 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.4 | GO:0000992 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) |
0.1 | 2.5 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 3.8 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 2.5 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.1 | 6.4 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 0.8 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 0.8 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.1 | 1.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 0.7 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 2.1 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.9 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 5.0 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 0.9 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.1 | 1.7 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 0.4 | GO:0017130 | poly(C) RNA binding(GO:0017130) |
0.1 | 0.5 | GO:0004641 | phosphoribosylamine-glycine ligase activity(GO:0004637) phosphoribosylformylglycinamidine cyclo-ligase activity(GO:0004641) phosphoribosylglycinamide formyltransferase activity(GO:0004644) |
0.1 | 6.0 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.5 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.1 | 3.7 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.1 | 2.6 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 1.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 0.5 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
0.1 | 1.1 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 2.9 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.1 | 0.5 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
0.1 | 1.1 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 2.6 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 0.6 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.1 | 0.4 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
0.1 | 0.6 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 0.5 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.1 | 2.7 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 1.4 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.1 | 3.8 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 2.2 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 1.1 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 4.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.5 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.1 | 0.8 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.1 | 0.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 21.6 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 6.0 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 0.7 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 0.3 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
0.1 | 2.5 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 0.4 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.1 | 3.6 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 2.1 | GO:0000150 | recombinase activity(GO:0000150) |
0.1 | 0.9 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 1.3 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 4.2 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 4.0 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 2.1 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 0.4 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 0.5 | GO:0036080 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
0.1 | 16.3 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 0.7 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 1.8 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 0.7 | GO:0019213 | deacetylase activity(GO:0019213) |
0.1 | 2.2 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 1.0 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.1 | 1.3 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.1 | 0.3 | GO:0004817 | cysteine-tRNA ligase activity(GO:0004817) |
0.1 | 1.2 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 0.8 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 0.3 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.1 | 0.7 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.1 | 0.6 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.1 | 1.0 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 2.0 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.4 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.1 | 0.4 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
0.1 | 3.2 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 1.2 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 0.3 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
0.1 | 0.4 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.1 | 2.0 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 0.4 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
0.1 | 1.9 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 2.7 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.1 | GO:0004818 | glutamate-tRNA ligase activity(GO:0004818) |
0.1 | 0.7 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.1 | 0.1 | GO:0048257 | 3'-flap endonuclease activity(GO:0048257) |
0.1 | 1.2 | GO:0048156 | tau protein binding(GO:0048156) |
0.1 | 0.4 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.1 | 1.4 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 3.3 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.1 | 0.2 | GO:1904854 | proteasome core complex binding(GO:1904854) |
0.1 | 0.3 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.1 | 0.2 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.1 | 2.1 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 3.4 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.2 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
0.1 | 0.4 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.1 | 2.8 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.1 | 3.2 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.6 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 0.3 | GO:0016708 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) fatty acid peroxidase activity(GO:0047888) |
0.1 | 2.9 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 0.3 | GO:0005334 | norepinephrine:sodium symporter activity(GO:0005334) |
0.1 | 0.8 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.1 | 1.7 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 1.3 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.7 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.1 | 0.7 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.1 | 0.4 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.1 | 0.7 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.1 | 1.8 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.1 | 0.1 | GO:0004096 | catalase activity(GO:0004096) |
0.1 | 3.2 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 0.4 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.1 | 0.6 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 0.5 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 3.0 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 1.3 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 42.6 | GO:0032561 | guanyl ribonucleotide binding(GO:0032561) |
0.1 | 0.5 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 1.3 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 3.9 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 0.3 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 1.7 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 0.4 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 13.5 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 0.5 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.1 | 0.3 | GO:0004572 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572) |
0.1 | 2.2 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.1 | 0.2 | GO:0097643 | amylin receptor activity(GO:0097643) |
0.1 | 0.2 | GO:0016517 | interleukin-12 receptor activity(GO:0016517) |
0.1 | 0.8 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.1 | 1.2 | GO:0004559 | alpha-mannosidase activity(GO:0004559) mannosidase activity(GO:0015923) |
0.1 | 2.0 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 4.8 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 1.3 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 0.7 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
0.1 | 1.5 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 1.2 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.4 | GO:0004797 | deoxycytidine kinase activity(GO:0004137) thymidine kinase activity(GO:0004797) |
0.1 | 0.5 | GO:0042835 | BRE binding(GO:0042835) |
0.1 | 1.1 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 1.2 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.2 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.1 | 0.2 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.1 | 0.9 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 3.0 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.1 | 0.3 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 1.0 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 1.0 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.1 | 1.2 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.1 | 0.8 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 3.7 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.1 | 12.3 | GO:0001047 | core promoter binding(GO:0001047) |
0.1 | 0.4 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.1 | 0.4 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.1 | 0.4 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.1 | 0.4 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 4.4 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.1 | 2.4 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.1 | 0.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 0.4 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.1 | 0.3 | GO:0070736 | protein-glycine ligase activity, initiating(GO:0070736) |
0.1 | 1.1 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.1 | 2.6 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.1 | 4.8 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.0 | 2.4 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 2.6 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.5 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.0 | 0.2 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
0.0 | 0.2 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.0 | 0.6 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.2 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.0 | 0.1 | GO:0004823 | leucine-tRNA ligase activity(GO:0004823) |
0.0 | 0.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.0 | 0.2 | GO:0052836 | inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
0.0 | 1.6 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.2 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
0.0 | 0.2 | GO:0030957 | Tat protein binding(GO:0030957) |
0.0 | 1.3 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.0 | 1.1 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.0 | 0.2 | GO:0033592 | RNA strand annealing activity(GO:0033592) RNA strand-exchange activity(GO:0034057) |
0.0 | 0.2 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.0 | 4.0 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.0 | 0.4 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.0 | 0.1 | GO:0008892 | guanine deaminase activity(GO:0008892) |
0.0 | 3.6 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.0 | 0.1 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
0.0 | 5.2 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.0 | 1.5 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.1 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.0 | 0.3 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.8 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.1 | GO:0097689 | iron channel activity(GO:0097689) |
0.0 | 0.3 | GO:0036132 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.0 | 0.5 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.0 | 0.4 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.0 | 0.2 | GO:0016296 | oleoyl-[acyl-carrier-protein] hydrolase activity(GO:0004320) myristoyl-[acyl-carrier-protein] hydrolase activity(GO:0016295) palmitoyl-[acyl-carrier-protein] hydrolase activity(GO:0016296) acyl-[acyl-carrier-protein] hydrolase activity(GO:0016297) |
0.0 | 1.4 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.0 | 0.3 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.0 | 10.8 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.6 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.1 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.0 | 5.5 | GO:0003729 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.0 | 1.0 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.7 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.7 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 0.8 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.0 | 0.1 | GO:0048040 | UDP-glucuronate decarboxylase activity(GO:0048040) |
0.0 | 1.4 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 1.4 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.5 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.0 | 1.0 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.7 | GO:0001083 | transcription factor activity, RNA polymerase II basal transcription factor binding(GO:0001083) |
0.0 | 0.3 | GO:0032183 | SUMO binding(GO:0032183) |
0.0 | 0.1 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
0.0 | 0.5 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.0 | 0.1 | GO:0042356 | GDP-4-dehydro-D-rhamnose reductase activity(GO:0042356) GDP-L-fucose synthase activity(GO:0050577) |
0.0 | 0.4 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.0 | 0.8 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 0.1 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.0 | 1.9 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 1.4 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 49.6 | GO:0003700 | transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.0 | 0.5 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 1.2 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 0.1 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.0 | 1.6 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.0 | 0.9 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 2.3 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.8 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 2.2 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 0.1 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) aspartic-type endopeptidase inhibitor activity(GO:0019828) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 0.2 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.0 | 0.4 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.0 | 0.3 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.0 | 0.9 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.0 | 0.3 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.3 | GO:0004386 | helicase activity(GO:0004386) |
0.0 | 0.0 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.7 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.9 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.0 | 0.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 6.4 | GO:0005198 | structural molecule activity(GO:0005198) |
0.0 | 0.1 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.0 | 0.0 | GO:0004651 | polynucleotide 5'-phosphatase activity(GO:0004651) |
0.0 | 0.4 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.1 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
0.0 | 0.2 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.0 | 0.2 | GO:0052794 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.0 | 1.5 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
0.0 | 0.3 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.0 | 0.9 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.1 | GO:0047946 | glutamine N-acyltransferase activity(GO:0047946) |
0.0 | 0.3 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.0 | 0.1 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.0 | 0.1 | GO:0008670 | 2,4-dienoyl-CoA reductase (NADPH) activity(GO:0008670) |
0.0 | 0.5 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.2 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 9.8 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.0 | 0.1 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 0.2 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.0 | 0.3 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.0 | 0.4 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.0 | 0.4 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.1 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.0 | 0.2 | GO:0035240 | dopamine binding(GO:0035240) |
0.0 | 0.3 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.1 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.0 | 0.1 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
0.0 | 0.2 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.0 | 0.3 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 1.2 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.0 | 0.2 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 0.1 | GO:0090409 | malonyl-CoA synthetase activity(GO:0090409) |
0.0 | 0.2 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.1 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.0 | GO:0050254 | rhodopsin kinase activity(GO:0050254) |
0.0 | 0.1 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
0.0 | 0.1 | GO:0030331 | estrogen receptor binding(GO:0030331) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 5.1 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.4 | 13.9 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.3 | 2.5 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.3 | 7.9 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.3 | 0.6 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.3 | 39.7 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.2 | 7.3 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.2 | 2.7 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.2 | 7.6 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.2 | 9.6 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 11.5 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.2 | 3.3 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.2 | 11.6 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.2 | 9.9 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.2 | 10.1 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.2 | 0.9 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 1.6 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 1.3 | ST STAT3 PATHWAY | STAT3 Pathway |
0.1 | 3.2 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 6.0 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 1.4 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 5.5 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 12.0 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 8.3 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 3.2 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 8.7 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 7.7 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 3.2 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 2.2 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 4.2 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 0.3 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 1.2 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 1.4 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 0.6 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 3.4 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 16.5 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 1.6 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 8.5 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 7.0 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 6.2 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 1.1 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 4.6 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 2.2 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 6.8 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 1.7 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 10.3 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 3.4 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 0.6 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.1 | 7.2 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 0.4 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 1.9 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 2.7 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 0.3 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 3.2 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 2.3 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 1.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 16.4 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 1.5 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 3.4 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 1.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 3.2 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 1.9 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 1.7 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.6 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.9 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 0.6 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 1.8 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.1 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 1.1 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 2.1 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 1.6 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.8 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 0.7 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 10.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.2 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 1.4 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 2.8 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.4 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 1.3 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.6 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 1.2 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.5 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 2.0 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.1 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.8 | PID CMYB PATHWAY | C-MYB transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 0.6 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.5 | 23.4 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.4 | 19.7 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.3 | 2.3 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.3 | 5.1 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.3 | 3.9 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.3 | 9.0 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.3 | 3.7 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.3 | 17.6 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.3 | 11.0 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.3 | 5.1 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.3 | 12.1 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 4.1 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.2 | 4.3 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.2 | 2.4 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.2 | 1.9 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.2 | 3.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.2 | 4.9 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.2 | 2.6 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.2 | 7.8 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.2 | 5.7 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.2 | 4.7 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.2 | 0.8 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.2 | 1.8 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.2 | 2.7 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.2 | 5.7 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.2 | 10.5 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.2 | 0.6 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 0.6 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.1 | 7.6 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 5.4 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 4.4 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 7.3 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 2.7 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 2.9 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 3.5 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 4.4 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 0.9 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 5.6 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 1.7 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 5.3 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 1.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 1.1 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.1 | 2.5 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 2.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 9.6 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 0.6 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.1 | 15.2 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 2.4 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 3.8 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 2.3 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 1.3 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 8.4 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 1.9 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 1.0 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 2.3 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 3.4 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 1.9 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 1.6 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 6.7 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 0.7 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 0.9 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 3.8 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 2.0 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 1.5 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 1.3 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 1.2 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 1.1 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.1 | 3.1 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 1.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.1 | 17.5 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 0.5 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.1 | 1.9 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 0.7 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 4.5 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.1 | 32.3 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.1 | 1.3 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 5.9 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 1.0 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 1.8 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 1.9 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 1.9 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 0.7 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 0.8 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.1 | 2.4 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 0.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 1.1 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 18.3 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 1.6 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 1.3 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 3.5 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 0.5 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 1.1 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.4 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.0 | 2.5 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.0 | 2.3 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 4.6 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 1.1 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 0.6 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 1.9 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 1.2 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.7 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 1.9 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 0.2 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 7.3 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 1.1 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.1 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.0 | 0.5 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.5 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.8 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 0.9 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.6 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.2 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.0 | 0.2 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.0 | 0.3 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 0.3 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.0 | 0.4 | REACTOME GABA B RECEPTOR ACTIVATION | Genes involved in GABA B receptor activation |
0.0 | 0.1 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.0 | 0.1 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.0 | 0.5 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |